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RESEARCH ARTICLE
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ÖZET
Amaç: Koroner arter hastalarında oksidatif/ antioksidatif 
dengenin oksidatif taraf lehine kaydığı bilinmektedir. Bu 
çalışmanın amacı, total antioksidan durum, oksidatif yük 
ve koroner arter hastalığı arasındaki ilişkiyi incelemektir.
Gereç ve yöntem:  Çalışma  grubu,  koroner Anjiyogra-
fi yapmak için hastaneye yatırılan ardışık 87 hastadan 
oluşmaktadır. Plazma total oksidatif durum (TOD) ve total 
antioksidan kapasite (TAK) seviyeleri ölçüldü ve oksidatif 
stres indeksi (OSİ) hesaplandı.
Bulgular: Dördüncü gruptaki TAK değerleri ilk grup (1.9 
± 0.2 vs 2.0 ± 0.2 mmol Trolox Eq/l) ile karşılaştırıldığın-
da istatistiksel olarak anlamlı derecede artmıştı ve birinci 
gruptaki hastalar ile karşılaştırıldığında, dördüncü grupta-
ki ( 5.2 ± 2.8 vs 7.2 ± 5.4 µmol H2O2 Eq/l) TOD değerle-
rindeki azalma anlamlı değildi. Hastalıklı damar sayısına 
göre, plazma oksidatif özellikleri üç grup arasında farklı 
bulunmadı.
Sonuç:  Plazma  TAK  düzeyleri  koroner  arter  hastalığı 
olan kişilerde artmıştır ve koroner aterosklerozun ağırlığı 
TAK ile ilişkilidir.
Anahtar kelimeler: Koroner arter hastalığı, total antioksi-
dan kapasite, oksidatif yük
ABSTRACT
Objectives: It was known that oxidative/antioxidative bal-
ance shifted to oxidative side in patients with coronary 
artery disease. The aim of this study is to evaluate the 
relationship between coronary artery disease and total 
antioxidant status, oxidative stress index.
Materials and methods: The study group consisted of 
87 consecutive patients who were hospitalized for coro-
nary  angiography.  Plasma  total  oxidative  status  (TOS) 
and total antioxidative capacity (TAC) levels were mea-
sured and oxidative stress index (OSI) was calculated.
Results: The TAC values increased statistically signifi-
cant in the four tertile compared with the first tertile (1.9 
± 0.2 vs 2.0 ± 0.2 mmol Trolox Eq/l) and the TOS values 
decreased non- significantly in the four tertile ( 5.2 ± 2.8 
vs 7.2 ± 5.4 µmol H2O2 Eq/l) as compared to the patients 
in the first tertile. According to the number of diseased 
vessels, plasma oxidative characteristics did not differ be-
tween the three groups.
Conclusions: Plasma TAC levels increased in subjects 
with  coronary  atherosclerosis  and  severity  of  coronary 
atherosclerosis  is  related  with  TAC.  J Clin Exp Invest 
2012; 3(1): 22-28
Key words: coronary artery disease; total antioxidant ca-
pacity; oxidative stress
INTRODUCTION
Cardiovascular disease is the leading cause of mor-
bidity and mortality in industrialized countries. Re-
active oxygen species (ROS) such as superoxide 
anion, hydrogen peroxide and hydroxyl radicals are 
produced during normal cellular function and their 
high  chemical  reactivity  leads  to  the  oxidation  of 
lipids, proteins or DNA. The balance between ROS 
generation and antioxidant activity is critical to the 
pathogenesis of oxidative stress-related disorders.1 
Oxidative stress to lipids and DNA caused by free 
radicals are known to be one of the several funda-
mental biological mechanisms that are responsible 
for developing atherosclerosis.2,3
Oxidants were increased and antioxidants were 
decreased, and because of these, oxidative/antioxi-
dative balance shifted to oxidative side in patients 
with coronary artery disease (CAD).4 Antioxidants M. Aydın et al. Antioxidant capacity and severity of coronary artery disease 23
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have been hypothesized to inhibit lipid peroxidation 
and therefore may play a protective role in the de-
velopment of cardiovascular disease by preventing 
the formation of early atherosclerotic lesions.5
Plasma concentrations of antioxidants can be 
measured separately in laboratory, but these mea-
surements  are  time-consuming,  labor-intensive, 
and costly. Therefore, several methods have been 
developed to determine the antioxidative capacity 
of various biological samples.6 Since antioxidative 
effects  of  antioxidant  components  of  plasma  are 
additive, the measurement of total antioxidant ca-
pacity  (TAC)  can  reflects  the  antioxidative  status 
of plasma.7,8 Individual metabolites may not neces-
sarily reflect the whole condition. Therefore, when 
seeking  a  specific  relationship  between  oxidative 
metabolism and suggested diseases, an evaluation 
of total antioxidant-oxidant capacity is essential.
Previous studies showed that the plasma TAC 
was significantly reduced in patients with CAD as 
compared with healthy subjects.9,10 In the present 
study, we aimed to investigate the oxidative/ anti-
oxidative status in patients with CAD and their rela-
tionships with the extent of CAD according to Gen-
sini score.
MATERIALS AND METHODS
The  study  was  conducted  at  the  Departments  of 
Cardiology and Clinical Biochemistry. Eighty-seven 
patients with angiographically demonstrated coro-
nary  vessel  status  were  evaluated  for  this  study. 
Informed consent for participation in the study was 
obtained from all patients. Institutional ethics com-
mittee approval was obtained. Past medical history, 
habitual  status  and  current  medications  were  re-
corded.
Exclusion criteria were heart failure, immuno-
logical disease, metabolic disease, history or pres-
ence  of  neoplastic  disease,  liver  and  kidney  dis-
ease, age over 70 years, acute and chronic inflam-
matory disease, diabetes mellitus and recent major 
surgical procedure. None of the patients was taking 
antioxidant drug therapy.
The patients who had total cholesterol level of 
>220 mg/dl or triglyceride concentration >200 mg/
dl, or receiving lipid-lowering drugs were defined as 
having  hyperlipidemia.  Hypertension  was  defined 
as a diastolic blood pressure ≥90 mmHg, systolic 
blood pressure ≥140mmHg or self-reported use of 
an  antihypertensive  drug.  Smokers  were  defined 
as those who had been smoking regularly (smoking 
daily for at least 1 year) until admission.
All  patients  in  the  study  underwent  selective 
coronary  angiography  (Philips Allura  Xper  FD10) 
after  appropriate  patient  preparation. Angiograms 
were performed for the investigation of ischaemic 
heart disease based on clinical indications (typical 
and  atypical  chest  discomfort  or  abnormal  stress 
test result). Two experienced cardiologists, blind to 
the patients’ clinical characteristics and biochemical 
results, reviewed all the angiographic images.
The severity of coronary artery stenosis was 
assessed and classified according to the American 
Heart Association System.11 The percentage steno-
sis of the coronary artery was determined by hand-
held calliper measurement. Significant angiograph-
ic coronary stenosis was defined as the presence 
of stenosis > 70% of the luminal diameter. Multi-
vessel disease (VD) was defined as the presence 
of significant stenosis in more than one of the three 
major epicardial coronary arteries. The presence of 
stenosis in the left main coronary artery with >50% 
luminal diameter was also considered to be multi-
vessel disease.
The Gensini score was calculated for each pa-
tient from the coronary arteriogram and was com-
puted by assigning a severity value to each coro-
nary  stenosis  according  to  the  degree  of  luminal 
narrowing and its locational importance. Reduction 
in  the  lumen  diameter  and  the  roentgenographic 
appearance  of  concentric  lesions  and  eccentric 
plaques were evaluated (reductions of 25%, 50%, 
75%, 90%, 99% and complete occlusion were given 
Gensini scores of 1, 2, 4, 8, 16, and 32, respec-
tively). The score was then multiplied by a factor 
relative to the importance of the lesion’s location 
in the coronary arterial tree: for example, 5 for left 
main coronary artery, 2•5 for proximal left anterior 
descending  coronary  artery  and  proximal  left  cir-
cumflex coronary artery (3•5 if left circumflex coro-
nary artery is dominant), 1•5 for mid-region of the 
left anterior descending coronary artery; 1 for distal 
left anterior descending coronary artery, the first di-
agonal, the proximal, mid- and distal-region of the 
right coronary artery, the postero-descending, the 
mid and distal-region of the left circumflex coronary 
artery (2 for both of them if left circumflex coronary 
artery is dominant) and the obtus margin, and 0•5 
for  the  second  diagonal  and  the  postero-lateral 
branch.12
Blood  samples  were  obtained  following  an 
overnight  fasting  state  before  coronary  angiogra-
phy. Samples were withdrawn from a cubital vein 
into blood tubes and stored at −80 °C. The serum 
was separated from the cells by centrifugation at 
3.000 rpm for 10 min and then analyzed.M. Aydın et al. Antioxidant capacity and severity of coronary artery disease 24
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Total oxidant status of plasma was measured 
using a novel automated colorimetric measurement 
method for TOS developed by Erel.8 In this method 
oxidants present in the sample oxidize the ferrous 
ion-o-dianisidine complex to ferric ion. The oxidation 
reaction is enhanced by glycerol molecules, which 
are abundantly present in the reaction medium. The 
ferric ion makes a colored complex with xylenol or-
ange in an acidic medium. The color intensity, which 
can be measured spectrophotometrically, is related 
to the total amount of oxidant molecules present in 
the sample. The assay is calibrated with hydrogen 
peroxide and the results are expressed in terms of 
micromolar hydrogen peroxide equivalent per liter 
(μmol H2O2 Eq/l).
Total antioxidant capacity of plasma was mea-
sured using a novel automated colorimetric mea-
surement method for TAC developed by Erel.7 In 
this method, the hydroxyl radical, the most potent 
biological radical, is produced by the Fenton reac-
tion and it reacts with the colorless substrate O-di-
anisidine to produce the dianisyl radical, which is 
bright yellowish-brown in color. Upon the addition 
of a plasma sample, the oxidative reactions initiated 
by the hydroxyl radicals present in the reaction are 
suppressed by the antioxidant components of the 
plasma, preventing the color change and thereby 
providing  an  effective  measurement  of TAC. The 
assay results were expressed as mmol Trolox Eq/l, 
and the precision of this assay is excellent, being 
lower than 3%.
The ratio of TOS to TAC was accepted as the 
oxidative stress index (OSI). For calculation, the re-
sulting unit of TAC was converted to mmol/l, and the 
OSI value was calculated according to the following 
formula: OSI (arbitrary unit) =TOS (μmol H2O2 Eq/l) 
/ TAC (mmol Trolox Eq/l).13
Statistical analysis
Results were expressed as mean ± S.D. or median 
(range) values for all continuous variables. Differ-
ences subjects were assessed using the Student’s 
t-tests and  chi-square  test. Associations  between 
severity of coronary atherosclerosis, TAC and other 
variables were evaluated by Pearson’s correlation 
test. The independence of these associations was 
evaluated  by  multiple  linear  regression  analysis. 
Patients were grouped according to severity of cor-
onary  atherosclerosis  involved,  and  comparisons 
among the groups were performed by using ANOVA 
test. A p < 0.05 was considered statistically signifi-
cant. Analysis was done with SPSS 11.0 statistical 
software.
RESULTS
Clinical  characteristics  of  patients  are  presented 
in Table1. The mean age in the study group was 
43.5 ± 10.9 years, 63% were men, 59% were hyper-
tensive, 13% were smokers. Mean Gensini score, 
mean plasma levels of TAC, TOS, OSI, total choles-
terol, LDL cholesterol, HDL cholesterol and triglyc-
erides are reported in Table 1.
Table 1. Baseline demographic, laboratory and treatment 
data characteristics
Mean value
Age (years) 43.5 ± 10.9
Gender (male, %) 63%
Total cholesterol (mg/dl) 194.8 ± 40 (69-289)
LDL cholesterol (mg/dl) 120.9 ± 35.1 (31-214)
HDL cholesterol (mg/dl) 40.9 ± 11.7 (19-91)
Triglyceride (mg/dl) 164 ± 96 (57-556)
Gensini Score  31 ± 40 (0-159)
TAC (mmol Trolox equivalent/l) 2.0 ± 0.2 (1.47-2.6)
TOS (µmol H2O2 eq/l) 6.6 ± 4.0 (4.7-28.4)
OSI (AU) 0.33 ± 0.1 (0.09-1.2)
ACE inhibitor (n) 21
ARB (n) 17
Beta blocker (n) 30
Calcium channel blockers (n) 17
Diuretics (n) 19
Statins (n) 18
Smoking, % 13
TAC, total antioxidant capacity; TOS, total oxidative sta-
tus; OSI, oxidative stress index; ACE, angiotensin-con-
verting  enzyme  inhibitors;  ARB,  angiotensin  receptor 
blocker
We divided the patients in four subgroups ac-
cording to quartiles of Gensini score level. The de-
mographic, biological and treatment characteristic 
of the four subgroups according to Gensini quartiles 
are depicted in Table 2.
There was statistically significantly higher inci-
dence of hypertension in the four tertile compared 
with the first tertile of Gensini score (p for trend = 
0.001). The use of betablockers, statine and angio-
tensin converting enzime inhibitors was also statisti-
cally significantly higher in the four tertile compared M. Aydın et al. Antioxidant capacity and severity of coronary artery disease 25
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with the first tertile of Gensini score (p for trend were 
0.0001, 0.0001 and 0.01 respectively).
As regards the lipid profile, the mean values of 
total cholesterol, LDL cholesterol and triglycerides 
did not differ significantly between subgroups. HDL 
cholesterol  values  decreased  in  the  four  tertile  ( 
37±11; 40±10, p for trend = 0.02) as compared to 
the patients in the first tertile.
Across  the  Gensini  quartiles  the TAC  values 
increased statistically significant in the four tertile 
compared with the first tertile (1.9 ± 0.2 vs 2.0 ± 
0.2 mmol Trolox Eq/l; p for trend = 0.03) and the 
TOS values decreased non- significantly in the four 
tertile ( 5.2 ± 2.8 vs 7.2 ± 5.4 µmol H2O2 Eq/l; p for 
trend = 0.13) as compared to the patients in the first 
tertile. As regards the OSI, did not differ significantly 
between Gensini subgroups. (p for trend = 0.09 ).
The  correlations  between  Gensini  score  and 
oxidative  characteristics  are  listed  in  Table  3.  A 
significant positive correlation was found between 
Gensini score and TAC, presence of hypertension 
(r = 0.243, p = 0.023), (r = 0.30, P = 0.005) and sig-
nificant negative correlation with OSI (r = -0.234, p 
= 0.02). In multiple linear regression analysis, pres-
ence of hypertension (Beta=0.4; p=0.03) were the 
only statistically significant independent predictors 
that correlated with the Gensini score values Table 
4.
Comparisons of variables according to number 
of significant coronary stenosis vessels are inves-
tigated. Patients with CAD divided into three cat-
egories according to the number of diseased ves-
sels: one-VD (16), two-VD (13), and three-VD (11). 
Slight increased TAC was observed in the three-VD 
compared with the two-VD and one-VD categories 
but  this  difference  was  not  statistically  significant 
(2.15±0.2, 2.03±0.2 and 2.01±0.2, p > 0.05). Also, 
the slight decrease in TOS and OSI was observed 
in the three-VD category but this difference was not 
statistically  significant  (6.7±3.4,  6.4±4.2,  5.4±2.8 
and 0.33±0.1, 0.32±0.2, 0.24±0.1 p > 0.05).
Table2. Demographic, laboratory and treatment data in the four Gensini score tertiles
Gensini tertile 1st Tertile
(n=22)
2nd Tertile
(n= 20 )
3rd Tertile
(n= 25 )
4rd Tertile
(n= 20)
P for trend
Age (years) 44.7±10.7 43.7±11.4 42.2±10.6 43.6±10.6
Gender (male; female) 8/14 13/7 17/8 17/3
Total cholesterol (mg/dl) 201±30.0  180±27  199±40  196±54 0.3
LDL cholesterol (mg/dl) 126±35  114±26  118±32  125±45 0.3
HDL cholesterol (mg/dl) 44±10 37±10 44±13 37±11 0.02
Triglyceride (mg/dl) 149±114 146±71 179±89 176±111 0.2
TAC (mmol Trolox equivalent/l) 1.9±0.2 1.9±0.2 2.07±0.2  2.0±0.2 0.03
TOS (µmol H2O2 eq/l) 7.2±5.4 6.1±2.8 7.6±3.9 5.2±2.8 0.139
OSI (AU) 0.36±0.24 0.32±0.13 0.36±0.18 0.33±0.18 0.09
ACE inhibitor, % 4.5 15 36 42.1 0.01
ARB, % 22.7 15 24 15.8 0.8
Beta blocker, % 4.5 20 52.0 63 0.001
Calcium channel Blockers, % 9.1 15.0 32 21.1 0.24
Diuretics, % 13.6 15 24 36.8 0.27
Statins, % 0 0 36 47.4 0.001
Hypertension, % 27.3 55 76 84.2 0.001
Smoking, % 21.4 26.7 11.8 20 0.76
TAC, total antioxidant capacity; TOS, total oxidative status; OSI, oxidative stress index; LDL cholesterol - low density 
lipoprotein cholesterol; HDL cholesterol - high density lipoprotein cholesterol; ACE - angiotensin conversion enzyme; 
ARB - angiotensin receptor blockers.M. Aydın et al. Antioxidant capacity and severity of coronary artery disease 26
J Clin Exp Invest   www.jceionline.org   Vol 3, No 1, March 2012
Table 3. Correlations between the Gensini score, TAC, TOS, OSI, Hypertension, LDL cholesterol, smoking
Gensini
 score
TAC (mmol Trolox
 equivalent/l)
TOS (µmol H2O2
 eq/l)
OSI 
(AU)
Hypertension
LDL cholesterol
(mg/dl)
Smoking
Total cholesterol
(mg/dl)
r 0.243  -0.17 -0.234 0.30 -0.026 -0.001 -0.06
P 0.023 0.10 0.02 0.005 0.8 0.9 0.56
TAC, total antioxidant capacity; TOS, total oxidative status; OSI, oxidative stress index; LDL cholesterol - low density 
lipoprotein cholesterol
in the pathogenesis of atherosclerosis.16 There are 
encouraging  correlation  between  DNA  oxidation 
and TAC in smokers, however plasma TAC in smok-
ers imprecisely higher than nonsmokers.17 Oxida-
tive stress induces macrophage responses such as 
increased capacity to oxidize LDL, increased oxi-
dized-LDL celluler uptake, as well as macrophage 
lipid peroxidation and increased intimal accumula-
tion of smooth muscle cells.18 Regnström et al.19 de-
scribed an inverse association between resistance 
of LDL to oxidation and severity of coronary steno-
sis in patients; however, the study of Croft et al.20 did 
not reveal a difference in oxidation parameters be-
tween coronary atherosclerotic patients and control 
subjects. On the other hand as a consequence of 
using lipid-lowering therapy (Atorvastatin 10mg/kg), 
%7.6 elevated TAC plasma levels were achieved.21 
Plasma OSI, the ratio of total plasma TOS level to 
TAC, is an indicator of oxidative stress, reflecting 
the redox balance between oxidation and antioxida-
tion.8,13 We demonstrated that an inverse associa-
tion between oxidative parameters (TOS, OSI) and 
the extent coronary artery disease but the associa-
tion is statistically non-significantly.
It is well-known that various antioxidants in plas-
ma have an additive effect, protecting the organism 
from fee radicals.22 In this respect, measurement 
of TAC provides information about the antioxidant 
capacity  of  organism.7  Previous  studies  showed 
that plasma antioxidant capacity was significantly 
reduced  in  patients  with  CAD.  Demirbag  et  al.10 
showed that TAC is decreased and DNA damage 
is increased in CAD patients compared with normal 
subjects. The DNA damage is negatively correlated 
wit TAC and it is positively correlated with severity 
of CAD. In another study, Demirbag et al.23 found a 
strong correlation between the TAC level and se-
verity of aortic atherosclerosis. Unlike, our results 
showed that TAC levels increased in subjects with 
coronary atherosclerosis and severity of coronary 
atherosclerosis is positively related with TAC.
Many studies have investigated by what mech-
anisms the endogenous antioxidants in plasma and 
LDL inhibit lipid peroxidation and oxidation of LDL. 
Table 4. Multivariate regression analysis for the Gensini 
score. Model summary 
Model R R Square Adjusted R Square Sig.
(2-tailed)
0.64 0.42 0.14 0.18
Multivariate analysis
Beta Sig (2 tailed)
(Constant)
TAC (mmol Trolox equivalent/l) 0.000 0.9
TOS (µmol H2O2 eq/l) -0.19 0.9
OSI (AU)  -0.22 0.8
Hypertension 0.4 0.03
Total cholesterol (mg/dl) -14.4 0.2
HDL cholesterol (mg/dl) 13.0 0.2
Smoking 0.11 0.5
TAC, total antioxidant capacity; TOS, total oxidative sta-
tus; OSI, oxidative stress index; HDL cholesterol - high 
density lipoprotein cholesterol; CI, Confidence Interval
DISCUSSION
The  present  study  investigated  plasma  oxidative 
stres markers, TAC, TOS and OSI. We report for the 
first time a significant association between elevated 
levels of TAC, lower OSI and increased coronary 
artery lesions objectively assessed by coronary an-
giography.
These factors were not shown to be indepen-
dently associated in multivariate analysis with the 
Gensini score. The slight increase in TAC and the 
slight decrease OSI was observed in the three-VD 
group.
In  the  literature  there  are  various  outcomes 
about antioxidan and TAC levels in diverse studies. 
A number of report in the literature implicate exces-
sive oxidative stress and/or inadequate antioxidant 
defences in the pathogenesis of cardiovascular risk 
and disease.14,15 In addition to traditional risk factors, 
oxidative stress and lipid peroxidation are involved M. Aydın et al. Antioxidant capacity and severity of coronary artery disease 27
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These studies have focused mainly on vitamin C, 
vitamin  E  and  carotenoids.  Jialal  et  al.  indicated 
that  combined  supplementation  with  antioxidants 
resulted in a significant inhibition of LDL oxidation. 
These findings also point to the significance of ad-
ministration of antioxidant therapy for the managent 
of CAD.2,24,25
Raising TAC  levels  of plasma  accompanying 
low  blood  pressure  and  low  lipid  peroxidation  in 
obese patients could be acquired through by DASH 
diet.15 Despite the conflicting results in CAD, nega-
tive correlation only with TAC and the number of in-
jured vessels was widely recognized.
Physical  activity  is  known  to  have  beneficial 
health effects in patients with CAD. Many studies 
reported  that  fat  soluble  plasma  antioxidants  in-
crease after aerobic exercise and isometric exer-
cise in humans.26 Increasing TAC levels in our study 
may be due to intake dietary antioxidant nutrients 
and regular exercising.
Our  findings  can  be  explained  with  following 
possible mechanisms: (1) alteration of oxidant/anti-
oxidant balance on behalf of antioxidant capacity as 
a defensive process in patients with CAD, (2) use 
of agents with anti-oxidative effects such as ACE 
inhibitors and statins in patients with severe CAD. 
(3) as a part of antioxidant defensive mechanisms 
it may increase involved in oxidative stress or some 
other pathologies like smoking or CAD.
In conclusion, plasma TAC levels increased in 
subjects with coronary atherosclerosis and severity 
of coronary atherosclerosis is related with TAC.
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